申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US05753673A1
公开(公告)日:1998-05-19
Quinolinecarboxylic acid derivatives represented by the following formula: ##STR1## wherein C is hydroxymethyl, methoxy, ethoxy or morpholinyl, or pharmaceutically acceptable salts thereof exhibit a potent action for stimulating a serotonin 4 receptor. The compounds exhibit an action of enhancing the gastrointestinal motor function to improve the gastrointestinal conditions such as heartburn, anorexia, bowel pain, abdominal distension, etc., accompanied by chronic gastritis, diabetes mellitus or postoperative gastroparesis, and are thus effective for the treatment of gastro-esophagal reflux, intestinal pseudo-obstruction and constipation.
以下公式所示的喹啉羧酸衍生物:##STR1## 其中C是羟甲基,甲氧基,乙氧基或吗啡啉基,或其药学上可接受的盐,表现出强效刺激5-羟色胺4受体的作用。这些化合物表现出增强胃肠道运动功能的作用,改善胃灼热,厌食,肠绞痛,腹胀等胃肠道疾病,如慢性胃炎,糖尿病或术后胃麻痹,并且因此对治疗胃食管反流,肠假性梗阻和便秘有效。